Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Myocardial infarction associated with erenumab: a case report.

< BACK TO ARCHIVE


2022 May 27


Pharmacotherapy


http://www.ncbi.nlm.nih.gov/pubmed/35620946?dopt=Abstract

Myocardial infarction associated with erenumab: a case report.

Authors

Myocardial infarction associated with erenumab: a case report.
Perino J, Corand V, Laurent E, Théophile H, Miremont-Salamé G, Pariente A, Colas J-L, Couffinhal T, Salvo F
Pharmacotherapy. 2022 May 27.
PMID: 35620946.

Abstract

Monoclonal antibodies acting on the calcitonin gene related peptide or its receptor (CGRP-mabs) are novel drugs for resistant migraine prophylaxis. As CGRP-mabs cause inhibition of vasodilatation, their use is reserved to patients with no recent history of cardiovascular diseases. We report a case of myocardial infarction associated with erenumab.
Read This Paper